Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Pancreatic Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00429858
What this trial is testing

Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Andrew Ko 21
Testing effectiveness (Phase 2)Study completedNCT02043730
What this trial is testing

Abraxane and Gemcitabine Versus Gemcitabine Alone in Locally Advanced Unresectable Pancreatic Cancer.

Who this might be right for
Pancreatic Cancer Stage II
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente 124
Testing effectiveness (Phase 2)Study completedNCT05068752
What this trial is testing

Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer

Who this might be right for
Pancreas Cancer
HonorHealth Research Institute 10
Early research (Phase 1)Study completedNCT00316420
What this trial is testing

Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Swedish Medical Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04644068
What this trial is testing

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

Who this might be right for
Ovarian CancerBreast CancerPancreatic Cancer+10 more
AstraZeneca 702
Large-scale testing (Phase 3)Study completedNCT00498225
What this trial is testing

Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Taiho Pharmaceutical Co., Ltd. 834
Not applicableUnknownNCT04112836
What this trial is testing

Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerExocrine Pancreatic InsufficiencyMetastatic Pancreatic Cancer+3 more
Moscow Clinical Scientific Center 186
Testing effectiveness (Phase 2)Active Not RecruitingNCT04098081
What this trial is testing

1911GCCC: Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Advanced Pancreatic Cancer
University of Maryland, Baltimore 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT05632328
What this trial is testing

AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC

Who this might be right for
Advanced Pancreatic Ductal AdenocarcinomaPancreatic Ductal AdenocarcinomaPancreatic Cancer
Bruno Bockorny 24
Early research (Phase 1)UnknownNCT06078800
What this trial is testing

YL-17231 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Shanghai YingLi Pharmaceutical Co. Ltd. 80
Large-scale testing (Phase 3)Study completedNCT00040183
What this trial is testing

OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.

Who this might be right for
Pancreatic Cancer
OSI Pharmaceuticals 569
Testing effectiveness (Phase 2)Active Not RecruitingNCT01585805
What this trial is testing

Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8+1 more
National Cancer Institute (NCI) 83
Early research (Phase 1)Study completedNCT01010945
What this trial is testing

Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
OSI Pharmaceuticals 19
Testing effectiveness (Phase 2)Study completedNCT00350142
What this trial is testing

Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Albert Koong 20
Early research (Phase 1)Study completedNCT03849469
What this trial is testing

XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Who this might be right for
MelanomaCervical CarcinomaPancreatic Carcinoma+20 more
Xencor, Inc. 78
Testing effectiveness (Phase 2)Looking for participantsNCT07226856
What this trial is testing

BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Pancreatic AdenocarcinomaRecurrent Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8
Mayo Clinic 43
Not applicableActive Not RecruitingNCT07122466
What this trial is testing

Early Treatment ctDNA Dynamics to Predict Response to Chemotherapy

Who this might be right for
Metastatic Pancreatic Cancer
Northwell Health 24
Testing effectiveness (Phase 2)Study completedNCT03180437
What this trial is testing

Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Fuda Cancer Hospital, Guangzhou 62
Testing effectiveness (Phase 2)Looking for participantsNCT06435260
What this trial is testing

Hypofractionated Radiotherapy +Chemotherapy+ Camrelizumab as Neoadjuvant Therapy for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Hebei Medical University Fourth Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06914674
What this trial is testing

Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas

Who this might be right for
Pancreatic Neoplasms
Fudan University 30
Next Page